ENDRA Life Sciences (NDRA)
(Delayed Data from NSDQ)
$4.79 USD
-0.01 (-0.21%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $4.90 +0.11 (2.30%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth C Momentum C VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
NDRA 4.79 -0.01(-0.21%)
Will NDRA be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for NDRA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NDRA
What Makes ENDRA Life Sciences (NDRA) a New Strong Buy Stock
NDRA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for NDRA
Is NDRA preparing to trend higher? 200 Day Moving Average Support shows up after slipping 0.21%
Is NDRA building bullish momentum? 200 Day Moving Average Support shows up after advancing 1.91%
Is NDRA ready to move higher? 200 Day Moving Average Support shows up after slipping 1.46%
NDRA forms Non-ADX 1,2,3,4 Bearish on September 16
200 Day Moving Average Support appears for NDRA after 2.74% move